Parexel International Clinical Research gets CDSCO Panel nod to study Dexpramipexole dihydrochloride monohydrate Dr. Divya Colin21 Oct 2024 5:45 PM ISTNew Delhi: Parexel has a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) to...
Parexel named "Best Contract Research Organization" at 17th Annual ViE Awards Ruchika Sharma8 April 2024 5:43 PM ISTDurham: Parexel, a clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, has announced...
Peyton Howell to become next CEO of Parexel Ruchika Sharma19 March 2024 12:26 PM ISTMumbai: Parexel, a clinical research organization (CRO) providing the full range of Phase I to IV clinical development services, has announced...
AstraZeneca unveils health tech business Evinova Ruchika Sharma21 Nov 2023 1:30 PM ISTEvinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally.
Frost and Sullivan recognizes Parexel with 2022 Global Customer Value Leadership Award Ruchika Sharma26 Oct 2022 9:30 AM ISTNew Delhi: Based on its recent analysis of the global decentralized clinical trials (DCT) industry, Frost & Sullivan has recognized global...
CDSCO panel opines Paraxel to study either CKD or heart failure in phase IIb trial of AZD9977,Dapagliflozin FDC Susmita Roy25 Sept 2022 1:28 PM ISTNew Delhi: In line with Paraxel's clinical trial protocol to study efficacy and safety of AZD9977 in combination with dapagliflozin in patients with...
Include more govt sites: CDSCO Panel to Parexel on Clinical Trial of Guselkumab Dr. Divya Colin15 July 2022 6:00 PM ISTNew Delhi: Highlighting the need of including more number of government sites to have the sites geographically distributed in the country, the Subject...
EQT Private Equity, Goldman to buy clinical research firm Parexel for USD 8.5 billion Ruchika Sharma4 July 2021 9:00 AM ISTNew Delhi: Clinical research firm Parexel has recently announced the execution of a definitive merger agreement under which it will be acquired...
